RA CAPITAL MANAGEMENT, LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RA CAPITAL MANAGEMENT, LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RA CAPITAL MANAGEMENT, LLC. RA CAPITAL MANAGEMENT, LLC is a 10% Owner in LIPID SCIENCES INC/ ($LIPD) and a 10% Owner in TG THERAPEUTICS, INC. ($TGTX) and a Director in KalVista Pharmaceuticals, Inc. ($CBYL) and a 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and a Director in Dicerna Pharmaceuticals Inc ($DRNA) and a Director in Kala Pharmaceuticals, Inc. ($KALA) and a Director in Ra Pharmaceuticals, Inc. ($RARX) and a 10% Owner in Verastem, Inc. ($VSTM) and a 10% Owner in Forma Therapeutics Holdings, Inc., ($FMTX) and a 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and a in G1 Therapeutics, Inc. ($GTHX) and a 10% Owner in Synthorx, Inc. ($THOR) and a 10% Owner in scPharmaceuticals Inc. ($SCPH) and a Director in Wave Life Sciences Ltd. ($WVE) and a 10% Owner in Vaxcyte, Inc. ($PCVX) and a 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a in ARVINAS INC. ($ARVN) and a 10% Owner in Iterum Therapeutics plc ($ITRM) and a 10% Owner in IMARA Inc. ($IMRA) and a Director in Satsuma Pharmaceuticals, Inc. ($STSA) and a 10% Owner in Inozyme Pharma, Inc. ($INZY) and a 10% Owner in PMV Pharmaceuticals, Inc. ($PMVP) and a Director in Solid Biosciences Inc. ($SLDB) and a Director in Eidos Therapeutics, Inc. ($EIDX) and a 10% Owner in Inhibrx, Inc. ($INBX) and a 10% Owner in Orchard Therapeutics plc ($ORTX) and a Director in Orchard Therapeutics plc ($ORTX) and a Director in Werewolf Therapeutics, Inc. ($HOWL) and a 10% Owner in Nkarta, Inc. ($NKTX) and a Director in Nkarta, Inc. ($NKTX) and a 10% Owner in Phathom Pharmaceuticals, Inc. ($PHAT) and a Director in 89bio, Inc. ($ETNB) and a 10% Owner in Pandion Therapeutics, Inc. ($PAND) and a 10% Owner in iTeos Therapeutics, Inc. ($ITOS) and a Director in iTeos Therapeutics, Inc. ($ITOS) and a Director in Vor Biopharma Inc. ($VOR) and a 10% Owner in Dyne Therapeutics, Inc. ($DYN).

Address: 111 HUNTINGTON AVENUE, SUITE 610 BOSTON 02199 MA

Companies in which RA CAPITAL MANAGEMENT, LLC is an Insider

89bio, Inc.

Trading Symbol: ETNB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 4,736,214 shares
Latest Transaction: Sep 21 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Aclaris Therapeutics, Inc.

Trading Symbol: ACRS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 2,607,719 shares
Current Value: $65,844,905
Latest Transaction: Sep 19 2016
$ACRS Market Capitalization: $537.94M
$ACRS Previous Close: $25.25

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ARVINAS, INC.

Trading Symbol: ARVN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC:
Holdings: 1,847,002 shares
Latest Transaction: Oct 03 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Dicerna Pharmaceuticals Inc

Trading Symbol: DRNA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner, Director
Holdings: 5,074,013 shares
Current Value: $13,090,954
Latest Transaction: Dec 20 2017
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Dyne Therapeutics, Inc.

Trading Symbol: DYN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 2,145,045 shares
Latest Transaction: Sep 23 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Eidos Therapeutics, Inc.

Trading Symbol: EIDX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 1,103,847 shares
Latest Transaction: Jun 22 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Forma Therapeutics Holdings, Inc.

Trading Symbol: FMTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 5,011,651 shares
Latest Transaction: Jun 24 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

G1 Therapeutics, Inc.

Trading Symbol: GTHX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC:
Holdings: 1,723,304 shares
Latest Transaction: May 24 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

IMARA Inc.

Trading Symbol: IMRA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 829,348 shares
Latest Transaction: Mar 17 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Inhibrx, Inc.

Trading Symbol: INBX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 2,129,003 shares
Latest Transaction: Aug 24 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Inozyme Pharma, Inc.

Trading Symbol: INZY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 1,403,653 shares
Latest Transaction: Jul 28 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

iTeos Therapeutics, Inc.

Trading Symbol: ITOS
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RA CAPITAL MANAGEMENT, LLC: Director, 10% Owner
Holdings: 289,843 shares
Latest Transaction: Apr 05 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Iterum Therapeutics plc

Trading Symbol: ITRM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 11,651,597 shares
Latest Transaction: Feb 08 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Kala Pharmaceuticals, Inc.

Trading Symbol: KALA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 10,874,613 shares
Latest Transaction: Mar 13 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

KalVista Pharmaceuticals, Inc.

Trading Symbol: KALV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 1,441,070 shares
Latest Transaction: Oct 16 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

LIPID SCIENCES INC/

Trading Symbol: LIPD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 3,713,962 shares
Latest Transaction: Mar 28 2007

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Nkarta, Inc.

Trading Symbol: NKTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director, 10% Owner
Holdings: 260,819 shares
Latest Transaction: Apr 05 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Orchard Therapeutics plc

Trading Symbol: ORTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RA CAPITAL MANAGEMENT, LLC: Director, 10% Owner
Holdings: 9,126,418 shares
Latest Transaction: Feb 11 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Pandion Therapeutics, Inc.

Trading Symbol: PAND
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 1,408,912 shares
Latest Transaction: Jul 22 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Phathom Pharmaceuticals, Inc.

Trading Symbol: PHAT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 3,115,008 shares
Latest Transaction: Mar 15 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PMV Pharmaceuticals, Inc.

Trading Symbol: PMVP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 760,265 shares
Latest Transaction: Sep 29 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ra Pharmaceuticals, Inc.

Trading Symbol: RARX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 03 2020
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

RHYTHM PHARMACEUTICALS, INC.

Trading Symbol: RYTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 5,210,088 shares
Latest Transaction: Jul 02 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Satsuma Pharmaceuticals, Inc.

Trading Symbol: STSA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 566,011 shares
Latest Transaction: Apr 05 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

scPharmaceuticals Inc.

Trading Symbol: SCPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 3,247,005 shares
Latest Transaction: Apr 15 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Solid Biosciences Inc.

Trading Symbol: SLDB
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 787,586 shares
Latest Transaction: Apr 05 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Synthorx, Inc.

Trading Symbol: THOR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Jan 24 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

TG THERAPEUTICS, INC.

Trading Symbol: TGTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 12,629,868 shares
Current Value: $61,254,860
Latest Transaction: Sep 11 2020
$TGTX Market Capitalization: $259.97M
$TGTX Previous Close: $4.85

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Vaxcyte, Inc.

Trading Symbol: PCVX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 5,169,254 shares
Latest Transaction: Oct 09 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Verastem, Inc.

Trading Symbol: VSTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 16,142,051 shares
Current Value: $20,016,143
Latest Transaction: Jun 29 2020
$VSTM Market Capitalization: $44.39M
$VSTM Previous Close: $1.24

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Vor Biopharma Inc.

Trading Symbol: VOR
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 755,726 shares
Latest Transaction: Apr 05 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Wave Life Sciences Ltd.

Trading Symbol: WVE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 201,594 shares
Current Value: $5,815,987
Latest Transaction: Apr 05 2021
$WVE Market Capitalization: $681.95M
$WVE Previous Close: $28.85

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Werewolf Therapeutics, Inc.

Trading Symbol: HOWL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 1,915,546 shares
Latest Transaction: May 06 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of RA CAPITAL MANAGEMENT, LLC

Sentiment: All, ETNB, ACRS, ARVN, DRNA, DYN, EIDX, FMTX, GTHX, IMRA, INBX, INZY, ITOS, ITRM, KALA, KALV, LIPD, NKTX, ORTX, PAND, PHAT, PMVP, RARX, RYTM, STSA, SCPH, SLDB, THOR, TGTX, PCVX, VSTM, VOR, WVE, HOWL

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 06 2021HOWLWerewolf Therapeut ...RA CAPITAL MANAGEMENT, L.P.DirectorOption ExerciseC0.002,930,48200
May 06 2021HOWLWerewolf Therapeut ...RA CAPITAL MANAGEMENT, L.P.DirectorOption ExerciseC0.0016,606,06800
May 06 2021HOWLWerewolf Therapeut ...RA CAPITAL MANAGEMENT, L.P.DirectorBuyP16.00105,7881,692,608443,825338 K to 443.8 K (+31.29 %)
May 06 2021HOWLWerewolf Therapeut ...RA CAPITAL MANAGEMENT, L.P.DirectorBuyC0.00338,0370338,0370 to 338 K
May 06 2021HOWLWerewolf Therapeut ...RA CAPITAL MANAGEMENT, L.P.DirectorBuyP16.001,609,21225,747,3923,524,7581.9 M to 3.5 M (+84.01 %)
May 06 2021HOWLWerewolf Therapeut ...RA CAPITAL MANAGEMENT, L.P.DirectorBuyC0.001,915,54601,915,5460 to 1.9 M
Apr 05 2021STSASatsuma Pharmaceut ...RA CAPITAL MANAGEMENT, L.P.DirectorBuyJ5.91192,3871,137,0075,348,2415.2 M to 5.3 M (+3.73 %)

View all RA CAPITAL MANAGEMENT, LLC insider transactions.

What Is Legal Insider Trading?

Insider trading is the buying or selling of shares of a company by someone who has access to material, non-public information on the company. Legal insider trading is when company insiders - officers, directors, employees and 10% owners - buy or sell shares in their company in accordance with securities laws and regulations. More ...

What Is a Rule 10b5-1 Plan?

Rule 10b5 is one of the most important acts put forth by the SEC. It prohibits fraud, misrepresentation, and deceit in the sale and purchase of securities on national exchanges. More ...

Are IPOs Interesting for Small Investors?

Initial Public Offering is the first sale of stock by a privately owned company to the public. Companies negotiate a sale of their stock to an investment banker or several bankers that act as an underwriter for the offering. More ...

Contact us | Follow us on Twitter